16 December 2025
16 December 2025
China’s focus on first or best-in-class oncology drugs and innovative R&D will position it well in 2026 and beyond.
Entasis’ Nuzolvence and GSK’s Blujepa are the first antibiotic approvals in gonorrhoea in over 30 years in the US.
Akeega’s indicated usage now spans across mCSPC and mCRPC, widening the drug’s future market potential.
The submission is based on outcomes from the Phase III DELTA Teen trial of Anzupgo (delgocitinib) 20mg/g cream.
Swixx’s co-founders, along with its CEO and CFO, will maintain significant ownership stakes.
Dr Tommy Rhee, CEO of RheeGen, outlines how FDA crackdowns have revealed dangerous and unethical tissue sourcing practices.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
